Analysis of native proteins from biological fluids by biomolecular interaction analysis mass spectrometry (BIA/MS): exploring the limit of detection, identification of non-specific binding and detection of multi-protein complexes

被引:46
作者
Nedelkov, D [1 ]
Nelson, RW [1 ]
机构
[1] Intrins Bioprobes Inc, Tempe, AZ 85281 USA
关键词
BIA/MS; SPR; MALDI-TOF mass spectrometry; limit of detection; protein complexes; non-specific binding;
D O I
10.1016/S0956-5663(01)00229-9
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Biomolecular interaction analysis mass spectrometry (BIA/MS) is a two-dimensional analytical technique that quantitatively and qualitatively detects analytes of interests. In the first dimension, surface plasmon resonance (SPR) is utilized for detection of biomolecules in their native environment. Because SPR detection is non-destructive, analyte(s) retained on the SPR-active sensor surface can be analyzed in a second dimension using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. The qualitative nature of the MALDI-TOF MS analysis complements the quantitative character of SPR sensing and overcomes the shortcomings of the SPR detection stemming from the inability to differentiate and characterize multi-protein complexes and non-specific binding. In this work, the benefit of performing NIS analysis following SPR sensing is established. Retrieval and detection of four markers present in biological fluids (cystatin C, beta-2-microglobulin, urinary protein 1 and retinol binding protein) was explored to demonstrate the effectiveness of BIA/MS in simultaneous detection of clinically related biomarkers and delineation of non-specific binding. Furthermore, the BIA/MS limit of detection at very low SPR responses was investigated. Finally, detection of in-vivo assembled protein complexes was achieved for the first time using BIA/MS. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1071 / 1078
页数:8
相关论文
共 45 条
[1]   Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone [J].
Arsalane, K ;
Broeckaert, F ;
Knoops, B ;
Clippe, A ;
Buchet, JP ;
Bernard, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (03) :169-174
[2]   LOW-MOLECULAR-WEIGHT PROTEINS AS MARKERS OF ORGAN TOXICITY WITH SPECIAL REFERENCE TO CLARA CELL PROTEIN [J].
BERNARD, A ;
LAUWERYS, R .
TOXICOLOGY LETTERS, 1995, 77 (1-3) :145-151
[3]  
BERNARD AM, 1994, KIDNEY INT, pS34
[4]  
Bondarenko PV, 1999, J LIPID RES, V40, P543
[5]   MALDI MS and strategies for protein analysis [J].
Fenselau, C .
ANALYTICAL CHEMISTRY, 1997, 69 (21) :A661-A665
[6]  
FREEDHOFF MI, 1997, HDB OPTICAL PROPERTI, V2, P1
[7]  
GRUBB A, 1992, CLIN NEPHROL, V38, pS20
[8]  
Halatek T, 1998, EUR RESPIR J, V11, P726
[9]  
Henskens YMC, 1996, BIOL CHEM H-S, V377, P71
[10]   Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays [J].
Hermans, C ;
Aly, O ;
Nyberg, BI ;
Peterson, C ;
Bernard, A .
CLINICA CHIMICA ACTA, 1998, 272 (02) :101-110